Pet Pharm Biotech Co (ROCO:7762) EPS (Basic) : NT$0.36 (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co EPS (Basic)?

Pet Pharm Biotech Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$0.27. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.36.

Pet Pharm Biotech Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$0.27. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.36.

Pet Pharm Biotech Co's EPS without NRI for the six months ended in Dec. 2024 was NT$0.27. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.36.

During the past 12 months, Pet Pharm Biotech Co's average EPS without NRIGrowth Rate was 33.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Pet Pharm Biotech Co EPS (Basic) Historical Data

The historical data trend for Pet Pharm Biotech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co EPS (Basic) Chart

Pet Pharm Biotech Co Annual Data

Trend

Dec22

Dec23

Dec24

EPS (Basic)

-0.16

0.31

0.36

Pet Pharm Biotech Co Semi-Annual Data
	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	-	0.18	0.13	0.09	0.27

Pet Pharm Biotech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pet Pharm Biotech Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(14.505	-	0)	/	39.972
	=	0.36

Pet Pharm Biotech Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(11.14	-	0)	/	40.269
	=	0.28

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.36

Pet Pharm Biotech Co (ROCO:7762) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pet Pharm Biotech Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pet Pharm Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051

Website

https://www.petpharmbio.com

Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines